Introduction
Approximately 5-10% of cases of amyotrophic lateral sclerosis (ALS) are inherited via > 40 associated genes, and~20% of these familial ALS (FALS) cases are caused by over 160 different mutations of superoxide dismutase 1 (SOD1) (Peters et al., 2015; Renton et al., 2014; Taylor et al., 2016) . Mutant (mt) SOD1 is thought to cause FALS because of a gain in toxicity rather than a loss in enzyme activity (Borchelt et al., 1994) . Although a specific molecular mechanism underlying mtSOD1 toxicity has remained elusive, misfolding of the mutant protein has been hypothesized as being critical. A number of factors lead to the misfolding of mtSOD1, including certain mutations, metal deficiency (Bourassa et al., 2014; Galaleldeen et al., 2009; Hayward et al., 2002) and oxidation (Barber et al., 2006; Kabashi et al., 2007) ; these factors may also lead to misfolding of wild-type SOD1, which has been described in sporadic ALS (Ezzi et al., 2007; Rotunno and Bosco, 2015) .
We previously reported that mtSOD1 misfolding enables the protein to form a tetrameric channel-like structure in lipid bilayers that can have "toxic channel" activity, leading to motoneuronal death (Allen et al., 2012) . We now show that misfolded SOD1 specifically targets lipid bilayer domains composed of phosphatidylglycerol (PG). We also find that the amphiphilic tri-block copolymer P188 alleviates this membrane toxicity in vitro and ameliorates disease in G93ASOD1 transgenic mice, a mouse model of ALS. Consistent with our findings, P188 has been shown to loosely interact with certain membrane surfaces while forming an apposed molecular adlayer capable of protecting membranes from physicochemical damage in a variety of cell systems (Lee, 2002; Lee et al., 1993; Shelat et al., 2013) . These findings raise the possibility of a new therapeutic direction in which motoneurons in ALS are protected via stabilization of cellular membranes that are vulnerable to toxic SOD1 oligomers.
